[ Price : $8.95]
Federal Register notice: FDA classifies blood collection devices for cell-free nucleic acids into Class 2.[ Price : $8.95]
GSK says data from two clinical trials showed that depemokimab significantly reduces asthma exacerbations in patients with severe ...[ Price : $8.95]
FDA removes a partial clinical hold against Rezolutes RZ358 (ersodetug), an investigational drug for treating hypoglycemia caused ...[ Price : $8.95]
FDA clears a Femasys 510(k) for its diagnostic device for checking the fallopian tubes to confirm permanent birth control placemen...[ Price : $8.95]
The Association for Diagnostics and Laboratory Medicine raises significant concerns regarding the recent FDA final rule on laborat...[ Price : $8.95]
Federal Register notice: FDA classifies endoscopic pancreatic debridement devices into Class 2 (special controls).[ Price : $8.95]
CBER posts an updated standard operating policy and procedure (SOPP) manual entitled SOPP 8404: Refusal to File (RTF) Procedures. ...[ Price : $8.95]
FDA grants Travere Therapeutics full approval for Filspari (sparsentan) for slowing kidney function decline in adults with primary...